COP1 and type 2 diabetes mellitus: In this regard, the COP1 degradation axis has been recently shown to malfunction in T2D patient β cells with low-exocytotic capacity, whereby upregulated ETV1 suppresses insulin secretion via an inflammatory pathway38, suggesting a COP1-ETV1 axis preventing β cell failure at later stages of T2D.